Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lack

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Cell Death & Disease|August 16, 2022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilitiesOzlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 27, 2022
Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In VivoAlisan Kayabolen, Ugur Akcan, Doğancan Özturan, et al.
Frontiers in Immunology|March 16, 2023
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumoursSarah Dada, Samantha L S Ellis, Christi Wood, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Nature Cell Biology|April 12, 2022
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasisYun Zhang, Joana Liu Donaher, Sunny Das, et al.
Wellcome Open Research|December 24, 2016
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathwayPaul Fineran, Emyr Lloyd-Evans, Nathan A Lack, et al.
Cell Communication and Signaling : CCS|November 17, 2023
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Cell Death & Disease|August 16, 2022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilitiesOzlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 27, 2022
Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In VivoAlisan Kayabolen, Ugur Akcan, Doğancan Özturan, et al.
Frontiers in Immunology|March 16, 2023
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumoursSarah Dada, Samantha L S Ellis, Christi Wood, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Nature Cell Biology|April 12, 2022
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasisYun Zhang, Joana Liu Donaher, Sunny Das, et al.
Wellcome Open Research|December 24, 2016
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathwayPaul Fineran, Emyr Lloyd-Evans, Nathan A Lack, et al.
Cell Communication and Signaling : CCS|November 17, 2023
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Pageof 12